Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The agency will continue to work with state regulators, monitor the market, and take enforcement actions as necessary to prevent unsafe or fraudulent GLP-1 drugs from reaching U.S
Sufficient for about 150 applications
For patients with diabetes who use insulin or sulfonylureas, there is also a risk of hypoglycaemia when starting Wegovy, and dose adjustments of these medications may be needed
Limited long-term human data prevents definitive safety conclusions, but decades of research suggest low risk with proper use
US$ 24.71
US$ 26.47
US$ 25.48
US$ 24.10
US$ 29.41
US$ 25.99
